Technical Analysis for IDXG - Interpace Biosciences, Inc
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| A | 8.79 | 11.27% | 0.8900 |
IDXG closed up 11.27 percent on Thursday, April 22, 2021, on 86 percent of normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | N/A | N/A | Up |
| Historical IDXG trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing High | Bullish | 0.00% | |
| 180 Bullish Setup | Bullish Swing Setup | 0.00% | |
| New 52 Week High | Strength | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Wide Bands | Range Expansion | 11.27% | |
| Overbought Stochastic | Strength | 11.27% | |
| Bearish Engulfing | Bearish | 9.87% | |
| Inside Day | Range Contraction | 9.87% | |
| Wide Bands | Range Expansion | 9.87% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company was formerly known as Interpace Diagnostics Group, Inc. and changed its name to Interpace Biosciences, Inc. in November 2019. Interpace Biosciences, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Cancer California Diagnostic Tests Agilent Technologies Hewlett Packard Science And Technology In The United States Bioinformatics Pathology Services
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Cancer California Diagnostic Tests Agilent Technologies Hewlett Packard Science And Technology In The United States Bioinformatics Pathology Services
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 8.8 |
| 52 Week Low | 2.98 |
| Average Volume | 56,385 |
| 200-Day Moving Average | 0.0000 |
| 50-Day Moving Average | 0.0000 |
| 20-Day Moving Average | 7.0480 |
| 10-Day Moving Average | 8.1610 |
| Average True Range | 0.6567 |
| ADX | 42.5 |
| +DI | 29.5062 |
| -DI | 10.6047 |
| Chandelier Exit (Long, 3 ATRs ) | 6.8299 |
| Chandelier Exit (Short, 3 ATRs ) | 6.4101 |
| Upper Bollinger Band | 9.8616 |
| Lower Bollinger Band | 4.2344 |
| Percent B (%b) | 0.81 |
| BandWidth | 79.8411 |
| MACD Line | 0.9239 |
| MACD Signal Line | 0.8916 |
| MACD Histogram | 0.0324 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 9.7650 | ||||
| Resistance 3 (R3) | 9.6600 | 9.2300 | 9.6025 | ||
| Resistance 2 (R2) | 9.2300 | 8.9817 | 9.2825 | 9.5483 | |
| Resistance 1 (R1) | 9.0100 | 8.8283 | 9.1200 | 9.1150 | 9.4941 |
| Pivot Point | 8.5800 | 8.5800 | 8.6350 | 8.6325 | 8.5800 |
| Support 1 (S1) | 8.3600 | 8.3317 | 8.4700 | 8.4650 | 8.0859 |
| Support 2 (S2) | 7.9300 | 8.1783 | 7.9825 | 8.0317 | |
| Support 3 (S3) | 7.7100 | 7.9300 | 7.9775 | ||
| Support 4 (S4) | 7.8150 |
